Chemical formula: C₁₇H₁₆F₆N₂O Molecular mass: 378.312 g/mol PubChem compound: 4046
Mefloquine acts on and destroys the asexual intraerythocytic forms of the human malaria parasites: Plasmodium falciparum, P. vivax. P. malariae and P. ovale. It is effective in the treatment and prophylaxis of malaria.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| P01BC02 | Mefloquine | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BC Methanolquinolines |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| LARIAM Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Mefloquine is an active ingredient of these brands:
Austria (AT)
Cyprus (CY)Estonia (EE)
Finland (FI)
France (FR)
Hong Kong (HK)
Japan (JP)
Netherlands (NL)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
